SSRIs, Antidepressants and the HIMS Special Issuance
Antidepressant use is not an automatic career-ender — the FAA has a monitored special-issuance pathway for a limited set of approved SSRIs.
For years any antidepressant use meant no medical certificate. That changed: the FAA now allows certain pilots treated with a limited number of approved SSRIs to hold a certificate through a special issuance, under structured monitoring. This is general information, not medical advice — work it through with a qualified AME.
The approved-medication pathway
The FAA permits a special issuance for pilots taking one of a small, specific set of approved SSRIs (the commonly cited approved medications are fluoxetine, sertraline, citalopram and escitalopram — verify the current list, which the FAA updates, with a knowledgeable AME). The condition being treated must be mild to moderate and stable, with no disqualifying features, and the pilot must have been on a stable dose for a required period with no adverse side effects.
HIMS
The pathway runs through HIMS — the industry/FAA program originally built for substance-use monitoring and extended to mental-health cases. A HIMS AME and specialist evaluations (often including neuropsychological testing) build the case the FAA reviews. If approved, the special issuance (an Authorization) comes with ongoing monitoring requirements.
The worst move is to hide it
Untreated depression is itself a flight-safety hazard, and falsifying the medical application to conceal a condition or medication is a separate, serious violation. Many pilots are surprised that the approvable path exists — the key is to disclose, get proper evaluation, and follow the process. See also disqualifying conditions and special issuance.
---
*Reference and training only — not for navigation or as legal advice. Always consult the current 14 CFR, the AIM, your aircraft’s POH/AFM and a certificated flight instructor.*